Perspective Therapeutics CATX
NYSE CATX
$2.75 +0.02 (+0.73%)
At close: Oct 2, 2026 · 4:00 PM EDT

Perspective Therapeutics (CATX) Price to Sales (2011 - 2023)

Updated

Perspective Therapeutics' (CATX) Price to Sales was 78.61 for Q4 2023.

Analysis

Perspective Therapeutics (CATX) Price to Sales (2011 - 2023) Analysis & Trends

Dating back to Q1 2023, Perspective Therapeutics' Price to Sales record includes 4 quarters.

  • By year, Price to Sales came in at 4.08 in FY2022 (-50.6%), 8.26 in FY2021 (+107.3%), 3.99 in FY2020 (+5.5%) and 3.78 in FY2019 (-11.7%).
  • Per Business Quant data, the three quarters before Q4 2023 came in at 5.62 (Q3 2023), 13.63 (Q2 2023) and 10.01 (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Perspective Therapeutics 311.46 Mn 311.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 78.61
Sep 30, 2023 9.41
Jun 30, 2023 22.44
Mar 31, 2023 15.91
Sep 30, 2022 3.29
Jun 30, 2022 4.08
Mar 31, 2022 4.65
Dec 31, 2021 5.18
Sep 30, 2021 8.74
Jun 30, 2021 8.26
Mar 31, 2021 16.03
Dec 31, 2020 3.96
Sep 30, 2020 4.10
Jun 30, 2020 3.99
Mar 31, 2020 3.85
Dec 31, 2019 4.99
Sep 30, 2019 2.67
Jun 30, 2019 3.78
Mar 31, 2019 3.56
Dec 31, 2018 3.04
API Access

Perspective Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=CATX&period=max&api_key=YOUR_API_KEY